Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial (Q36369998)

13 August 2017

title

Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial (English)

1 reference

13 August 2017

0 references

6

Gerhard Rogler

1 reference

13 August 2017

4

Myriam Labopin

1 reference

13 August 2017

9

Dominique Farge

1 reference

13 August 2017

8

Jack Satsangi

1 reference

ORCID Public Data File 2021

13 August 2017

1 reference

author name string

James O Lindsay

1

1 reference

13 August 2017

Mathieu Allez

2

1 reference

13 August 2017

Miranda Clark

3

1 reference

13 August 2017

Elenor Ricart

5

1 reference

13 August 2017

Montserrat Rovira

7

1 reference

13 August 2017

Christopher J Hawkey

10

1 reference

13 August 2017

ASTIC trial group

11

1 reference

13 August 2017

European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party

12

1 reference

13 August 2017

European Crohn's and Colitis Organisation

13

1 reference

13 August 2017

publication date

6 April 2017

1 reference

The lancet. Gastroenterology & hepatology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

399-406

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

13 August 2017

1 reference

7 January 2021

Long-term prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Changes in the Lémann Index Values During the First Years of Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: long-term follow-up of UK patients treated on compassionate basis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Modelling valuations for Eq-5d health states: an alternative model using differences in valuations.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Stem Cell Transplantation for Refractory Crohn Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Stem Cell Transplantation for Refractory Crohn Disease--Reply

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Vedolizumab as induction and maintenance therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930056-0

7 January 2021

10.1016/S2468-1253(17)30056-0

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dgwjuvnfdrcehh57kre5b5mghu

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_dgwjuvnfdrcehh57kre5b5mghu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dgwjuvnfdrcehh57kre5b5mghu

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/dgwjuvnfdrcehh57kre5b5mghu

1 reference

30 July 2022